Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29706008 | 1.00 | PDK2 (0.31) | PDK2 | |
| SCHEMBL26444920 | 0.90 | PDK2 (0.33) | PDK2 | |
| SCHEMBL20208904 | 0.90 | PDK2 (0.33) | PDK2 | |
| SCHEMBL29706020 | 0.90 | PGR (0.33) | PDK2 | |
| SCHEMBL20208906 | 0.90 | PGR (0.33) | PDK2 | |
| SCHEMBL24976789 | 0.88 | KDM4E (0.35) | PDK2 | |
| SCHEMBL25561269 | 0.88 | PDK2 (0.31) | PDK2 | |
| SCHEMBL24913666 | 0.85 | KDM4E (0.32) | — | |
| SCHEMBL12704813 | 0.83 | PDK2 (0.34) | PDK2 | |
| SCHEMBL26190264 | 0.83 | PDK2 (0.31) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114940681-A | Electroactive compounds | 株式会社LG化学 | 2022-08-26 | — | — | CN | disclosed |
| CN-110023319-B | Electroactive compounds | 株式会社LG化学 | 2022-06-17 | — | — | CN | disclosed |
| US-11239426-B2 | Electroactive compounds | LG CHEM, LTD. | 2022-02-01 | — | — | US | disclosed |
| WO-2018097937-A1 | ELECTROACTIVE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11239426-B2 | Electroactive compounds | KCNN2, HCN2, KCNN3 | PDK2 1291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.